Simultaneous affinity maturation and developability enhancement using natural liability-free CDRs
Affinity maturation is often a necessary step for the development of potent therapeutic molecules.Many different diversification strategies have been used for antibody affinity maturation, including error-prone PCR, chain shuffling, and targeted complementary-determining region (CDR) mutation.Although effective, they can negatively impact antibody